NeoCast MMA Embolization for Subacute and Chronic Subdural Hematoma

NIH registered clinical trial NCT07541404 titled "MMA Embolization With NeoCast for Subacute and Chronic Subdural Hematoma" on ClinicalTrials.gov. The study evaluates the safety and efficacy of middle meningeal artery embolization using the NeoCast Embolic System for treatment of symptomatic subacute or chronic subdural hematoma as an adjunct to surgery. The trial lists NeoCast Embolic System and FDA-Approved Commercial Liquid Embolic as interventions.

Healthcare providers, particularly interventional neuroradiologists and neurosurgeons, should be aware of this trial as it may impact treatment protocols for subdural hematoma patients. Medical device manufacturers with competing embolic technologies may find this registration relevant for competitive intelligence and clinical development planning.